3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
14
Prostatic Neoplasms
3
Uterine Cervical Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pleural Effusion, Malignant
2
Ovarian Neoplasms
2
Leukemia, Myeloid, Acute
2
Infertility
2
Hodgkin Disease
2
Endometrial Neoplasms
2
Thyroid Nodule
1
Thromboembolism
1
Stomach Neoplasms
1
Soft Tissue Neoplasms
1
Small Cell Lung Carcinoma
1
Sexuality
1
Sexual Dysfunction, Physiological
1
Sarcoma
1
Risk Malignant Index
1
Renal Insufficiency, Chronic
1
Recurrence
1
Rectal Neoplasms
1
Popliteal Cyst
1
Polycystic Ovary Syndrome
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Neoplasms
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Interventions
Ultrasonography
2
Blood Specimen Collection
2
tislelizumab
1
Mammography
1
Lenalidomide
1
Immune Checkpoint Inhibitors
1
High-Energy Shock Waves
1
Cetirizine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Hypersensitivity
×
High-Energy Shock Waves
×
Clear all
NCT02834585
2016-07-15
MUSTT
University of Genova
Unknown
70 enrolled